TTM
$46.6B
YoY change
+5.7%
5Y CAGR
+5.1%
Peak year (FY2025)
$44.3B
Cumulative revenue
$896B
Revenue history chart for Abbott Laboratories (ABT) from 2016 to 2025
Latest: $44.3B
Revenue growth chart for Abbott Laboratories (ABT) from 2016 to 2025
Latest: +5.7%
Revenue history table for Abbott Laboratories (ABT) from 1985 to 2025
| FY2025 | $44.3B | +5.7% | +$2.38B | ||
| FY2024 | $42B | +4.6% | +$1.84B | ||
| FY2023 | $40.1B | -8.1% | -$3.54B | ||
| FY2022 | $43.7B | +1.3% | +$578M | ||
| FY2021 | $43.1B | +24.5% | +$8.47B | ||
| FY2020 | $34.6B | +8.5% | +$2.7B | ||
| FY2019 | $31.9B | +4.3% | +$1.33B | ||
| FY2018 | $30.6B | +11.6% | +$3.19B | ||
| FY2017 | $27.4B | +31.3% | +$6.54B | ||
| FY2016 | $20.9B | +2.2% | +$448M | ||
| FY2015 | $20.4B | +0.8% | +$158M | ||
| FY2014 | $20.2B | -7.3% | -$1.6B | ||
| FY2013 | $21.8B | -45.2% | -$18B | ||
| FY2012 | $39.9B | +2.6% | +$1.02B | ||
| FY2011 | $38.9B | +10.5% | +$3.68B | ||
| FY2010 | $35.2B | +14.3% | +$4.4B | ||
| FY2009 | $30.8B | +4.2% | +$1.24B | ||
| FY2008 | $29.5B | +13.9% | +$3.61B | ||
| FY2007 | $25.9B | +15.3% | +$3.44B | ||
| FY2006 | $22.5B | +0.6% | +$139M | ||
| FY2005 | $22.3B | +13.5% | +$2.66B | ||
| FY2004 | $19.7B | -0.0% | -$545K | ||
| FY2003 | $19.7B | +11.3% | +$2B | ||
| FY2002 | $17.7B | +8.6% | +$1.4B | ||
| FY2001 | $16.3B | +18.5% | +$2.54B | ||
| FY2000 | $13.7B | +4.3% | +$568M | ||
| FY1999 | $13.2B | +5.6% | +$700M | ||
| FY1998 | $12.5B | +5.0% | +$594M | ||
| FY1997 | $11.9B | +7.9% | +$870M | ||
| FY1996 | $11B | +10.0% | +$1B | ||
| FY1995 | $10B | +9.4% | +$856M | ||
| FY1994 | $9.16B | +8.9% | +$748M | ||
| FY1993 | $8.41B | +7.1% | +$556M | ||
| FY1992 | $7.85B | +14.2% | +$975M | ||
| FY1991 | $6.88B | +11.7% | +$718M | ||
| FY1990 | $6.16B | +14.5% | +$779M | ||
| FY1989 | $5.38B | +9.0% | +$443M | ||
| FY1988 | $4.94B | +12.5% | +$549M | ||
| FY1987 | $4.39B | +15.2% | +$580M | ||
| FY1986 | $3.81B | +13.3% | +$447M | ||
| FY1985 | $3.36B | — | — |
- FY2025$44.3B+5.7%
- FY2024$42B+4.6%
- FY2023$40.1B-8.1%
- FY2022$43.7B+1.3%
- FY2021$43.1B+24.5%
- FY2020$34.6B+8.5%
- FY2019$31.9B+4.3%
- FY2018$30.6B+11.6%
- FY2017$27.4B+31.3%
- FY2016$20.9B+2.2%
- FY2015$20.4B+0.8%
- FY2014$20.2B-7.3%
- FY2013$21.8B-45.2%
- FY2012$39.9B+2.6%
- FY2011$38.9B+10.5%
- FY2010$35.2B+14.3%
- FY2009$30.8B+4.2%
- FY2008$29.5B+13.9%
- FY2007$25.9B+15.3%
- FY2006$22.5B+0.6%
- FY2005$22.3B+13.5%
- FY2004$19.7B-0.0%
- FY2003$19.7B+11.3%
- FY2002$17.7B+8.6%
- FY2001$16.3B+18.5%
- FY2000$13.7B+4.3%
- FY1999$13.2B+5.6%
- FY1998$12.5B+5.0%
- FY1997$11.9B+7.9%
- FY1996$11B+10.0%
- FY1995$10B+9.4%
- FY1994$9.16B+8.9%
- FY1993$8.41B+7.1%
- FY1992$7.85B+14.2%
- FY1991$6.88B+11.7%
- FY1990$6.16B+14.5%
- FY1989$5.38B+9.0%
- FY1988$4.94B+12.5%
- FY1987$4.39B+15.2%
- FY1986$3.81B+13.3%
- FY1985$3.36B—
Revenue values are taken from Abbott Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current revenue (TTM) is $46.6B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Abbott Laboratories (ABT) most recent annual revenue stands at $44.3B (2025) – grew 5.7% year-over-year.
Across 2020–2025 (5 years), Abbott Laboratories revenue produced a CAGR of +5.1% – sustaining 2 straight years of year-over-year growth.
Across the available history, revenue reached its high of $44.3B in 2025 and its low of $3.36B in 1985.
Abbott Laboratories Revenue by Year
Abbott Laboratories Revenue 2025: $44.3B
Abbott Laboratories posted revenue of $44.3B in 2025, grew 5.7% from 2024. This figure represents the highest annual value in the available history.
Abbott Laboratories Revenue 2024: $42B
In 2024, Abbott Laboratories reported revenue of $42B, edged up 4.6% from 2023.
Abbott Laboratories Revenue 2023: $40.1B
Abbott Laboratories revenue in 2023 was $40.1B, declined 8.1% below 2022.
Abbott Laboratories Revenue 2022: $43.7B
2022's revenue for Abbott Laboratories came in at $43.7B, edged up 1.3% from 2021.
Abbott Laboratories Revenue 2021: $43.1B
Abbott Laboratories revenue in 2021 was $43.1B.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Revenue
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest revenue
| $448B | |
| $94.2B | |
| $65.2B | |
| $64.9B | |
| $61.2B | |
| $48.2B | |
| $44.6B | |
| $36.7B |
- $94.2B
- $65.2B
- $64.9B
- $61.2B
- $48.2B
- $36.7B
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.16% TTM
- Dividend Profile2.30% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.